Indivior (LON:INDV) Shares Down 1.2% - Should You Sell?

Indivior PLC (LON:INDV - Get Free Report) shares traded down 1.2% during mid-day trading on Wednesday . The stock traded as low as GBX 891 ($11.29) and last traded at GBX 897 ($11.37). 215,905 shares changed hands during trading, a decline of 81% from the average session volume of 1,137,238 shares. The stock had previously closed at GBX 908 ($11.51).

Wall Street Analyst Weigh In

Separately, Deutsche Bank Aktiengesellschaft reissued a "buy" rating and set a GBX 1,500 ($19.01) price target on shares of Indivior in a research note on Thursday, September 5th.

Indivior Trading Up 2.7 %

The stock has a market capitalization of £1.18 billion, a P/E ratio of -1,151.25, a P/E/G ratio of -5.57 and a beta of 0.19. The stock's 50 day moving average price is GBX 762.30 and its 200-day moving average price is GBX 929.55. The company has a quick ratio of 1.52, a current ratio of 0.85 and a debt-to-equity ratio of 2,790.00.

About Indivior

Indivior PLC, together with its subsidiaries, engages in the development, manufacture, and sale of buprenorphine-based prescription drugs for the treatment of opioid dependence and co-occurring disorders in the United States, the United Kingdom, and internationally. The company develops medicines to treat substance use disorders, serious mental illnesses, and opioid overdose.